Navigation Links
NYSE Amex LLC Accepts Plan of Compliance of The Quantum Group, Inc.
Date:6/3/2009

WELLINGTON, Fla., June 3 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (NYSE Amex: QGP) (the "Company"), announced today that on May 28, 2009, the NYSE Amex LLC (the "Exchange") accepted the Company plan of compliance with respect to its previously disclosed listing deficiency as set forth in Section 1003(a)(iv) of the Exchange Company Guide. The Company was afforded the opportunity to submit a plan of compliance to the Exchange and on April 15, 2009 presented its plan to the Exchange, with subsequent submissions to the plan. On May 28, 2009, the Exchange notified the Company that it accepted the Company plan of compliance and granted the Company an extension until September 17, 2009, to regain compliance with the continued listing standards. The Company will be required to provide the Exchange staff with updates in conjunction with the initiatives of the plan of compliance as appropriate or upon the Exchange's request and the Exchange staff will review the Company periodically for compliance with the plan of compliance during the extension period. Failure to make progress consistent with the plan of compliance or to regain compliance with the continued listing standards by the end of the extension period could result in the Company being delisted from the Exchange.

About The Quantum Group, Inc.

The Quantum Group is an innovation-driven Healthcare Services Organization (HSO) that provides business process solutions, service chain management, strategic consulting and leading edge technology to the healthcare industry.

Quantum has developed and deployed PWeR(TM) (www.myPWeR.com), a cutting-edge, patent-pending healthcare technology system that has been designed to bridge the gaps of communication and exchange of patient information throughout the healthcar
'/>"/>

SOURCE The Quantum Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. United States Patent and Trademark Office Accepts CoolTouch's Re-examination Request for Cynosure '873 Patent
2. NYSE Amex Accepts Interleukin Genetics Plan to Meet Continued Listing Standards
3. Gamma Pharmaceuticals Accepts PO From Leading St. Louis Missouri Distributor. Order Valued up to $850,000 Retail Market Value
4. FDA Accepts Nuvos Resubmission For Pennsaid(R)
5. ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain
6. Andre Konski, M.D., M.B.A., Accepts Radiation Oncology Position at Wayne State University and the Karmanos Cancer Institute
7. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
8. FDA accepts Labopharms response for once-daily tramadol as complete Class 2 response
9. FDA Accepts Gentas NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia
10. Partnering With MyPyramid: NUTRIKIDS Accepts the Challenge to Help Families Step Up to Healthier Living
11. AMEX Accepts Lorus Plan to Meet AMEXs Continued Listing Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... York (PRWEB) March 03, 2015 ... used to market the atypical antipsychotic medication continue ... According to court documents, the South Carolina Supreme ... that Johnson & Johnson’s Janssen Pharmaceuticals unit had ... risks. However, while the Court’s February 25th decision ...
(Date:3/3/2015)... Longtime parent visionary and inspiring new father, Lucas ... for a candid interview on the surrogacy process in ... revelation of his magical surrogacy journey — detailing the ... the birth of his precious twin girls. , ... Founder of CARE stated, “We are committed to maintaining ...
(Date:3/3/2015)... Man, Woman & Student of the Year ... and ensure access to treatments for blood cancer patients, ... their families. Through this annual national ten-week campaign, individuals ... a world without blood cancers. The national titles will ... to be announced this summer. To date, these dedicated ...
(Date:3/3/2015)... SC (PRWEB) March 03, 2015 The ... the public’s expectation of excellence in care and safe ... the position of the RNS that biologic infusions are ... under the direct supervision of a registered nurse (RN), ... reactions, including anaphylaxis can occur in patients receiving these ...
(Date:3/3/2015)... The human augmentation market is mainly driven ... wearable augmentation sector is predicted to outpace the in-built ... years. , The eye-wear sector dominates the North ... of new products launches in the region. Furthermore, strong ... as well as the rising demand for advantageous products ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2
... The American Association for Dental Research (AADR) has ... AADR William B. Clark Fellowship in Clinical Research. This ... Meeting & Exhibition in Washington, DC, March 3, 2010. ... Department of Periodontics, University of Texas, Health Science at ...
... ... children and we are working with our members to develop new tools to keep the ... ... International Consumer Product Health & Safety Organization’s (ICPHSO) CPSC Day in Washington, D.C. on February ...
... radiation may not be necessary for early malignancy, study ... alone offers a reasonable overall level of survival for ... new study suggests. , Traditional treatment regimens for limited ... study, researchers analyzed U.S. National Cancer Institute data on ...
... , ... ... ... ...
... ... vitamin and supplement retailer recently launched a robust health encyclopedia offering health news and ... knowledge and more. , ... Shelby Township, Mich. (PRWEB) February 19, 2010 -- eVitamins™, a leading online retailer ...
... Ecological, physiological similarities provide basis for insights, expert says, ... that dolphins suffer from diseases similar to those found ... on the effects that contaminated water and seafood have ... and their diet includes much of the same seafood ...
Cached Medicine News:Health News:JPMA Supports CPSC Chairman Tenenbaum's Continued Safety Efforts 2Health News:JPMA Supports CPSC Chairman Tenenbaum's Continued Safety Efforts 3Health News:JPMA Supports CPSC Chairman Tenenbaum's Continued Safety Efforts 4Health News:Jim Huber to Serve as National Spokesman for 'Know Your Score: Fight Prostate Campaign' at Myrtle Beach Golf Holiday in August 2Health News:Jim Huber to Serve as National Spokesman for 'Know Your Score: Fight Prostate Campaign' at Myrtle Beach Golf Holiday in August 3Health News:Jim Huber to Serve as National Spokesman for 'Know Your Score: Fight Prostate Campaign' at Myrtle Beach Golf Holiday in August 4Health News:Jim Huber to Serve as National Spokesman for 'Know Your Score: Fight Prostate Campaign' at Myrtle Beach Golf Holiday in August 5Health News:Jim Huber to Serve as National Spokesman for 'Know Your Score: Fight Prostate Campaign' at Myrtle Beach Golf Holiday in August 6Health News:eVitamins Launches New Health Encyclopedia 2Health News:Dolphins May Warn of Health Risks in Humans 2
(Date:3/3/2015)... 2015  Web Industries, Inc., a leading provider ... Medical Device, Advanced Composites, Consumer Products, and Wire ... Medical Specialties Preferred Converter by 3M,s Medical Specialties ... to streamline their supply chains by using Web ... materials, intermediate converting services, and contract manufacturing and ...
(Date:3/3/2015)... , March 3, 2015  AT&T 1 ... today announced that  AT&T  is the connectivity provider for ... was designed to help provide peace of mind to ... the freedom to live active lives with the confidence ... need it. The AT&T network 2 helps power ...
(Date:3/3/2015)... 3, 2015  Cyberonics, Inc. (NASDAQ: CYBX ... treatment and management of epilepsy, today announced it will ... March 11, 2015, in Miami . ... Chief Executive Officer, will speak at 1:05 PM Eastern ... chat format, and no formal materials will be presented.  ...
Breaking Medicine Technology:Web Industries Receives 3M Preferred Converter Status 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4
... Data presented at AACR 2008, SAN DIEGO, ... owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq,and ... demonstrating that,the Company,s experimental drug candidate, brostallicin, killed ... status. The study, conducted,by Cristina Geroni, Ph.D., et ...
... Inc.,(Nasdaq: MITI ), a biopharmaceutical company developing ... autoimmune diseases, today,presented at the Annual Meeting of ... Diego, CA, preclinical data of two new human ... of acute myelogenous,leukaemia (AML) and melanoma (1). BiTE ...
Cached Medicine Technology:Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability Based on Genetic Profiling 2Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability Based on Genetic Profiling 3Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 2Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 3Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 4Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 5
... Latex Foley Catheter, Smooth, non-stick silicone ... but flexible, latex-based construction with large ... round tip with two opposing eyes ... two staggered eyes and a 30cc ...
... 3-way design permits continuous irrigation ... in the Foley Catheter. 3-Way ... construction, as well as LUBRICATH ... variety of models including Suggs, ...
Red Latex Bardex I.C. Foley 2-Way Catheter (Council Model)...
All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: